Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of DA-302168S tablets in type 2 diabetes mellitus
CTR20263087Phase 2Active
- Sponsor
- Chengdu Di'ao Pharmaceutical Group
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DA-302168S in type 2 diabetes mellitus (T2DM), sponsored by Chengdu Di'ao Pharmaceutical Group. Started Aug 2026; status: active.
02
Drugs
DA-302168S
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20263087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263087.